These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9369955)

  • 21. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.
    Koźma EM; Olczyk K; Wisowski G; Głowacki A; Bobiński R
    J Biochem; 2005 Apr; 137(4):463-76. PubMed ID: 15858170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
    J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fine structural alterations of the palmar aponeurosis in Dupuytren's contracture. A combined scanning and transmission electronmicroscopic examination.
    Józsa L; Salamon A; Réffy A; Renner A; Demel S; Donhöffer A; Pintér T; Thöring J
    Zentralbl Allg Pathol; 1988; 134(1):15-25. PubMed ID: 3358315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contractile properties and responses to tensional loading of Dupuytren's disease--derived fibroblasts are altered: a cause of the contracture?
    Bisson MA; Mudera V; McGrouther DA; Grobbelaar AO
    Plast Reconstr Surg; 2004 Feb; 113(2):611-21; discussion 622-4. PubMed ID: 14758224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contraction of collagen lattices by cells from Dupuytren's nodules.
    Tarpila E; Ghassemifar MR; Wingren S; Agren M; Franzén L
    J Hand Surg Br; 1996 Dec; 21(6):801-5. PubMed ID: 8982933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of Dupuytren's contracture--a review].
    Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
    Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
    Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
    J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
    Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
    BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.
    Meek RM; McLellan S; Crossan JF
    J Bone Joint Surg Br; 1999 Jul; 81(4):732-8. PubMed ID: 10463754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
    Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
    Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pathobiochemistry of Dupuytren's contracture].
    Bobiński R
    Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.